The Stratus® CS Analyzer for acute care diagnostics provides quantitative cardiac assays for fast, accurate evaluation of patients presenting with suspected myocardial ischemia. Its efficiency and ease of use make it ideal for both point-of-care testing and lab applications.

• Easy to use and ideal for all skill levels
• Full cardiac menu including guideline acceptable troponin I and D-dimer (with pulmonary embolism exclusion) assays
• Results in as little as 14 minutes
• Customize up to 4 tests to run on a single patient sample in your acute care setting, helping you make a quick diagnosis
• Use in the acute care setting to decrease turnaround time, patient length of stay, and total patient costs

Features & Benefits

Managing Chest Pain to Meet the Challenge

Each year, more than eight million patients visit emergency departments in the United States with chest pain suggestive of myocardial ischemia. Yet, in around 75% of cases, objective evidence of unstable coronary syndrome is lacking after the initial clinical and ECG evaluation.

Accelerated diagnostic protocols using biochemical markers and near-patient testing strategies with the Stratus® CS analyzer can help address this challenge. Consequently, hospital stays—and the cost to manage both ACS-positive and ACS-negative patients—can be reduced.  

Fast, informative results

• Rapid turnaround time: 14 minutes to first result, and 4 minutes for each subsequent result
• A broad menu of tests to support better chest pain differentiation from a single sample, on a single run, on a single instrument
  • Troponin I – our guideline acceptable assay meets accreditation with an imprecision level of ≤10% at the 99th percentile of normal population.
  • D-Dimer assay with clinically validated claim to exclude pulmonary embolism
  • NT-proBNP – aids in the diagnosis and assessment of severity of congestive heart failure and used for risk stratification of patients with acute coronary syndrome and heart failure
  • Cardiophase® hsCRP – helpful for assessing risk of future cardiovascular disease
  • Quantitative ßhCG – early pregnancy detection to guide diagnostic testing decisions
  • CKMB Mass – an alternative to Troponin I to aid in the diagnosis of acute myocardial infarction
  • Myoglobin – an early biomarker to aid in the diagnosis of patients suspected of myocardial infarction

Easy-to-use in the Emergency Department, Coronary Care Unit, STAT Lab or Central Lab

• Simple operation for all skill levels: load sample, rotor, TestPak™ Cartridge(s)—and press Start
• System accepts blood directly from collection tube—no sample preparation, no manual dilutions
• Integrated centrifuge spins whole blood to plasma and automatically pipettes to test cartridges—no user manipulation needed

Efficient and cost-effective

• Eliminates manual intervention steps that prolong result turnaround
• Single use packaging for tests, calibrators, and diluents reduce reagent waste
• Select tests based on patient need—no fixed assay panels
• System Check (electronic QC) reduces liquid QC frequency requirements

Compliant

• Barcode readers and lockout features for near-patient testing compliance
• Fully compliant with OSHA Bloodborne Pathogens Preamble
• First to the market with a guideline acceptable troponin I assay with the low end precision to meet the 2012 ESC/ACC Guidelines

Extensive Support

• Onsite training
• Field service group
• Technical telephone support